Sep 30

SH 08 - Hematologic Malignancies - Science Highlights

10 - Phase II Multi-Institutional Study of Ultralow-Dose (4Gy) Response-Adapted Radiotherapy for Symptomatic Bone Metastases from Multiple Myeloma

09:30am - 09:35am ET

Room 109

Presenter(s)

Leslie Ballas, MD, FASTRO - Cedars Sinai, Los Angeles, CA